July 04, 2021
1 min read
Save
Via Surgical receives FDA clearance of closed-loop suture-based fixation system
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Via Surgical has announced FDA 510(k) clearance of the TissueTak tendon anchor, a closed-loop suture-based fixation system, according to a press release.
The TissueTak system, which is designed for arthroscopic rotator cuff repair and augmentation, uses a suture-based anchor that attaches the patch directly to the tendon, according to the release.
“In our clinical and biomechanical assessment, TissueTak showed superior strength for affixing biological patches to the tendons,” Ofek Levin, co-founder and chair of the board at Via Surgical, said in the release. “We’re excited to get our technology into more operating rooms, so we can help improve rotator cuff surgeries for both patients and doctors,” Levin added.
Published by:
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.